MENU
NBY
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
NovaBay Pharmaceuticals (NBY) Ownership - Who owns NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.44M
P/E Ratio
0.02
Total Cash
8.47M
Projected Growth
N/A
Total Debt
1.13M
Revenue
9.78M
Risk (Beta)
1.06
Dividend Yield
N/A
Total Cash/Share
1.46
Total Debt/Equity
N/A
Revenue/Share
2.07 USD as % of share price
Fundamentals
NBY
Capitalization
3.44M
P/E Ratio
0.02
Risk (Beta)
1.06
Dividend Yield
N/A
Total Cash
8.47M
Total Cash/Share
1.46
Total Debt
1.13M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.07%
Revenue
9.78M
ROE
N/A
Book Value
6.16M
P/B Ratio
0.56
Cash Flow
N/A
Earnings
28.86
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
58K
Current Ratio
2.95
Current Revenue Per Employee
93884.62
Dividends Per Share - Security
N/A
EBITDA
-6.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
65.26
Revenue To Assets
34.88
Shares Held By Institutions
257K
Shares Outstanding - Current
5.82M
Total Liabilities
3.71M
Total Volume MTD
N/A
Value
1
Gain YTD
-1.697
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com